CRON Stock Chart & Stats
$3.51
$0.07(2.55%)
At close: 4:00 PM EDT
$3.51
$0.07(2.55%)
Day’s Range― - ―
52-Week Range$2.28 - $3.61
Previous Close$2.02
Volume1.22M
Average Volume (3M)870.69K
Market Cap
$1.24B
Enterprise Value$410.50M
Total Cash (Recent Filing)$797.02M
Total Debt (Recent Filing)$1.29M
Price to Earnings (P/E)17.9
Beta0.53
Next Earnings
Nov 05, 2026EPS Estimate
0.03Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)0.19
Shares Outstanding368,412,870
10 Day Avg. Volume861,021
30 Day Avg. Volume870,689
Financial Highlights & Ratios
PEG Ratio0.83
Price to Book (P/B)0.92
Price to Sales (P/S)6.74
P/FCF Ratio6.63K
Enterprise Value/Market Cap0.33
Enterprise Value/Revenue2.29
Enterprise Value/Gross Profit5.05
Enterprise Value/Ebitda7.57
Forecast
1Y Price Target
$5.01Price Target Upside42.71% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering1
EPS Forecast (FY)0.12
Revenue Forecast (FY)$150.53M
Bulls Say, Bears Say
Bulls Say
Revenue And EBITDA GrowthRevenue and profit growth across the latest quarter, combined with the broader TTM rebound, indicates stronger demand and operating leverage rather than only isolated sales expansion. If maintained, this scale can support reinvestment and improve the durability of earnings.
Conservative Balance SheetDebt-to-equity near 0.1% and roughly $1.07B of equity against $1.18B of assets provide substantial financial resilience. This conservative funding base preserves flexibility to fund operations, absorb volatility, and pursue growth without relying heavily on borrowing.
Canadian Brand StrengthSpinach is gaining share across multiple high-value formats, with performance materially ahead of the industry. Sustained leadership in vapes, cartridges and edibles strengthens brand economics, distribution relevance and the platform for repeat sales in Canada's legal market.
Bears Say
Profitability Remains UnprovenDespite stronger operating results, slightly negative TTM net margin and the recent history of operating losses show that the turnaround has not yet translated into consistently positive bottom-line earnings. This leaves profitability more vulnerable if growth or margins soften.
Gross Margin VariabilityManagement says quarterly gross margin can vary with seasonality, geographic and product mix, and growing conditions. That variability makes reported profitability less predictable and means the recent margin expansion may not fully persist without consistent mix and operating execution.
Israel Regulatory ExposureAn anti-dumping investigation into Canadian medical-cannabis imports creates regulatory exposure in Israel, a key growth market. Even though Cronos disputes the allegations, an adverse outcome could affect market access, competitive conditions or economics and complicate expansion.
Cronos Group News
CRON FAQ
What was Cronos Group’s price range in the past 12 months?
Cronos Group lowest stock price was $2.28 and its highest was $3.61 in the past 12 months.
What is Cronos Group’s market cap?
Cronos Group’s market cap is $1.24B.
When is Cronos Group’s upcoming earnings report date?
Cronos Group’s upcoming earnings report date is Nov 05, 2026 which is in 7 days.
How were Cronos Group’s earnings last quarter?
Cronos Group released its earnings results on Aug 06, 2026. The company reported $0.09 earnings per share for the quarter, beating the consensus estimate of $0.01 by $0.08.
Is Cronos Group overvalued?
According to Wall Street analysts Cronos Group’s price is currently Undervalued.
Does Cronos Group pay dividends?
Cronos Group does not currently pay dividends.
What is Cronos Group’s EPS estimate?
Cronos Group’s EPS estimate is 0.03.
How many shares outstanding does Cronos Group have?
Cronos Group has 368,412,870 shares outstanding.
What happened to Cronos Group’s price movement after its last earnings report?
Cronos Group reported an EPS of $0.09 in its last earnings report, beating expectations of $0.01. Following the earnings report the stock price went up 12.868%.
Which hedge fund is a major shareholder of Cronos Group?
Currently, no hedge funds are holding shares in CRON
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Cronos Group Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$5.01 (42.71% Upside)
$5.01 (42.71% Upside)
Blogger Sentiment
Bullish
CRON Sentiment 75%
Sector Average 65%
Sector Average 65%
Crowd Wisdom
Negative
Last 7 Days ▲ 0.3%
Last 30 Days ▼ 1.0%
Last 30 Days ▼ 1.0%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Positive
20 days / 200 days
Momentum
34.53%
12-Months-Change
Fundamentals
Return on Equity
6.46%
Trailing 12-Months
Asset Growth
0.39%
Trailing 12-Months
Learn more about TipRanks Smart Score
Company Description
Cronos Group
Cronos Group Inc. functions as a diversified global cannabinoid enterprise. Within the United States, it manufactures, promotes, and distributes a variety of hemp-derived supplements and cosmetic products. These items are available under its Lord Jones and Happy Dance brands through online sales, traditional retail, and hospitality partner networks. The company also plays a significant role in the cultivation, production, and commercialization of cannabis and cannabis-infused products for both medicinal and adult-use sectors. Its comprehensive product offerings encompass dried cannabis flower, pre-rolled joints, edibles, concentrated forms, and cannabis extracts. These are distributed via wholesale partnerships and direct-to-consumer channels, prominently featuring its wellness platform, PEACE NATURALS, and its adult-use brand, Spinach. Moreover, Cronos Group exports dried cannabis and cannabis oils to international markets including Germany, Israel, and Australia. Established in 2012, the company maintains its corporate headquarters in Toronto, Canada.
CRON Earnings Call
Q2 2026
0:00 / 0:00
Earnings Call Sentiment|Positive
The call conveyed a broadly positive operational and financial picture: record revenue, gross profit, and adjusted EBITDA, strong brand performance (notably Spinach), meaningful international growth (Israel and Germany), and a robust cash position. Key risks and headwinds include a new anti-dumping investigation in Israel, modest OpEx increases, margin variability tied to seasonality and mix, and timing uncertainty around the CanAdelaar closing. On balance, the positive operational momentum and strong financials outweigh the highlighted risks.View all CRON earnings summariesCRON Stock 12 Month Forecast
Average Price Target
$5.01
▲(42.71% Upside)
Technical Analysis
Ownership Overview
4.53% Insiders
0.66% Mutual Funds
― Other Institutional Investors
92.50% Public Companies and
Individual Investors